News

Analysis of the Benefits of Combining Enalapril/Bisoprolol in Patients with Acute MI

13. 5. 2024 Source: Cardiovascular Continuum

A recently published retrospective analysis compared the outcomes achieved by administering enalapril alone and in combination with bisoprolol in patients after acute myocardial infarction over a period of 1 year.

New scoring system for predicting long-term survival of AML patients over 70 years and suitable for intensive chemotherapy

Based on the analysis of data from 3 large European registries (DATAML, SAL, and PETHEMA), a prognostic score for 5-year survival was created and validated for patients with acute myeloid leukemia…

10. 5. 2024 Source: Acute Myeloid Leukemia

Maintenance Therapy of a Female Patient with AML After Intense Chemotherapy –⁠ Case Study

The following case study presents the case of a female patient with acute myeloid leukemia (AML) who experienced life-threatening complications after the second consolidation chemotherapy, rendering…

10. 5. 2024 Source: Acute Myeloid Leukemia

Efficacy and Safety of Romosozumab in Postmenopausal Women with Osteoporosis and Renal Impairment

The coexistence of osteoporosis and chronic kidney disease (CKD) increases the risk of fractures and overall mortality in patients. A recent post-hoc analysis of two controlled randomized multicenter…

9. 5. 2024 Source: Osteoporosis – Trends in Sequential Therapy

Previous Treatment of Osteoporosis May Affect the Efficacy of Romosozumab

A study conducted by a team of authors from several clinical sites in Japan shows that the type and duration of previous osteoporosis treatment just before starting romosozumab affects its…

9. 5. 2024 Source: Osteoporosis – Trends in Sequential Therapy

Will 3D Printable Tissue Adhesives Replace Stitches and Clips?

3D printing technology is slowly making its way into more and more areas of healthcare. In February 2024, a scientific team from the Massachusetts Institute of Technology (MIT) published a study in…

8. 5. 2024 Source:

Over the Last 25 Years, Latanoprost Has Changed the Paradigm of Glaucoma Treatment

An important milestone in the treatment of glaucoma was the introduction of latanoprost with an entirely new mechanism of action compared to previously used antiglaucoma medications. Prostaglandin…

7. 5. 2024 Source: Treatment of Glaucoma

New Technology Teaches Healthcare Professionals to Deliver Messages Patients Don't Want to Hear

Communication with patients and their relatives is often very challenging for doctors and nurses, especially when the patient or their family member is experiencing strong emotions. A new technology…

3. 5. 2024 Source:

EAHAD 2024: Fresh results of paradigm5 and 6 studies confirm safety and efficacy of N9-GP

Nonacog beta pegol (N9-GP) is a recombinant factor IX with an extended half-life. Its properties allow for the maintenance of a satisfactorily high level of FIX with intravenous application once a…

30. 4. 2024 Source: Hemophilia with Movement

What is the future of xenotransplantation? Pig liver and kidneys transplanted to humans for the first time

The initial successes of pig organ transplants to humans, conducted this March, gave hope that clinical trials of these procedures could soon become a reality. What path then leads to the clinical…

30. 4. 2024 Source:

1 … 16 17 18 19 20 … 171

Back Filter by speciality

Remove filters